RPTOR and chronic myelogenous leukemia, BCR-ABL1 positive: In this study, increased phospho-mTORSer2448 and Raptor as well as increased active form of Rheb (Figure 2C) were significantly detected in K562RIMT cells (Figure 2A,B), indicating that the mTORC1 is activated in imatinib-resistant CML cells.